跳至主要内容
临床试验/ISRCTN15030282
ISRCTN15030282进行中(未招募)未知

Improving health-related quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support: a transnational effectiveness-implementation hybrid trial

niversity Medical Center Hamburg-Eppendorf0 个研究点目标入组 472 人开始时间: 2023年1月13日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
472

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36964518/ (added 27/03/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Effectiveness focus:
  • 1. Autoimmune rare liver disease (AIH, PSC, PBC)
  • 2. Subjective psychosocial support need
  • 3. =18 years
  • 4. Written informed consent
  • Implementation focus:
  • Stakeholders:
  • 1. Involvement in intervention delivery/implementation i.e. healthcare providers, patient representatives, health insurers
  • 2. Written informed consent

排除标准

  • Effectiveness focus:
  • 1. Life-threatening health-status
  • 2. Acute suicidality
  • 3. Ongoing psychotherapy
  • 4. Severe cognitive, auditory or visual impairment
  • 5. Inability to complete assessments
  • Implementation focus:
  • 1. Involvement in outcome assessment or data analysis

研究者

发起方
niversity Medical Center Hamburg-Eppendorf

相似试验